Systematic Assessment of Vascular Risk
NCT00378040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2016-05-16
Summary
It is hypothesized that patients with vascular disease are undertreated for modifiable risk factors, leading to increased morbidity and mortality in this population.
The objective of this study is to develop a comprehensive database that will demonstrate the current adequacy of risk factor management in this high risk population, and that will provide needed guidance for future treatment options.
Conditions
- Peripheral Vascular Disease
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Principal Investigators
-
Thomas Lindsay, M.D · Toronto General Hospital, University Health Network
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
- Primary Completion
- 2006-12-31
- Completion
- 2015-12-31
Countries
- Canada
Study Locations
More Related Trials
-
The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study
NCT02038530 ·Status: COMPLETED
-
Warfarin Anticoagulation in Patients in Sub-Saharan Africa
NCT03512080 ·Status: COMPLETED
-
Prospective Trial of a Validated Algorithm for Warfarin Dosing
NCT02705976 ·Status: COMPLETED ·Phase: NA
-
Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients
NCT03243708 ·Status: COMPLETED ·Phase: NA
-
Simple Warfarin Dosing Algorithm Study
NCT01008215 ·Status: COMPLETED ·Phase: NA
-
Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism
NCT02095925 ·Status: COMPLETED
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02776566 ·Status: COMPLETED ·Phase: NA
-
Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
NCT00788736 ·Status: COMPLETED
-
A Prospective Cohort Study on Warfarin Personalized Medication
NCT06428110 ·Status: COMPLETED
-
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
NCT03835780 ·Status: COMPLETED
-
Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)
NCT00157677 ·Status: COMPLETED ·Phase: PHASE3
-
High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion
NCT02570243 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
NCT01662908 ·Status: COMPLETED ·Phase: PHASE2
-
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
NCT01803022 ·Status: COMPLETED
-
Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome
NCT02562690 ·Status: UNKNOWN
-
Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants
NCT02720328 ·Status: COMPLETED ·Phase: PHASE4
-
Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion
NCT00123292 ·Status: TERMINATED ·Phase: PHASE2
-
Patient Convenience Study
NCT02597920 ·Status: COMPLETED
-
Direct Oral Anticoagulants and Venous Thromboembolism
NCT02833987 ·Status: COMPLETED
-
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
NCT01602432 ·Status: WITHDRAWN
-
Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with PAD:Phase II
NCT06850207 ·Status: NOT_YET_RECRUITING
-
Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection
NCT02258958 ·Status: COMPLETED
-
A Prospective Study to Assess the Risk Factors That Contribute to Thrombosis in Patients With Lower Limb Injuries.
NCT04608591 ·Status: UNKNOWN
-
Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
NCT02704598 ·Status: UNKNOWN ·Phase: NA
-
Below Knee DVT Study
NCT03805672 ·Status: TERMINATED ·Phase: PHASE4